Efficacy and safety of transvaginal mesh repair in a cohort with a minimum of 10-year follow-up

被引:0
作者
Zhibo Zhang
Jianbin Guo
Weijie Tian
Ye Zhang
Yuelun Zhang
Tianshu Sun
Jiali Duan
Xinmiao Bao
Yuan Wang
Yang Ye
Qianqian Gao
Honghui Shi
Abraham Nick Morse
Juan Chen
Lan Zhu
机构
[1] National Clinical Research Center for Obstetric and Gynecologic Diseases,Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
[2] Medical College of Guizhou University,Department of Gynecology, Guizhou Provincial People’s Hospital
[3] The First Affiliated Hospital of Zhengzhou University,Department of Obstetrics and Gynecology
[4] Chinese Academy of Medical Sciences & Peking Union Medical College,Medical Research Center, Peking Union Medical College Hospital
[5] Chinese Academy of Medical Sciences & Peking Union Medical College,Medical Doctor Program
[6] Peking Union Medical College Hospital,Department of Pathology
[7] Tufts University School of Medicine,undefined
来源
Science China Life Sciences | 2024年 / 67卷
关键词
complication; efficacy; long-term follow-up; pelvic organ prolapse; safety; transvaginal mesh;
D O I
暂无
中图分类号
学科分类号
摘要
Although transvaginal mesh (TVM) repair is no longer used in some countries, long-term outcomes after TVM surgery are of great importance globally. However, reports with follow-up >10 years are limited. Thus, this study aimed to report outcomes in a prospective cohort with at least 10 years of follow-up. Women with stage III–IV symptomatic prolapse were approached consecutively from 2008 to 2013 at one tertiary hospital. The main outcome measure was symptomatic failure. Secondary outcomes included anatomic failure, recurrence, patient satisfaction, complications, and reoperation. The Kaplan-Meier curve was used to estimate the cumulative failure rate. Of the 121 patients enrolled in the study, 103 (85.1%) completed a median follow-up of 11 years. The estimated probability rates of symptomatic and anatomic failure were 17.6% and 8.8% in 11 years, respectively. The estimated incidence of symptomatic failure increased by 8.2% between 5 and 11 years; however, the corresponding rate for anatomic failure was 3.7%. The most common complication was vaginal mesh exposure, and its estimated probability increased from 19.3% to 28.4% from 5 to 11 years, respectively. Office trimming resolved 80.0% of vaginal exposures. These patients did not report decreased overall satisfaction. Patients with vaginal mesh exposure requiring>3 office procedures or mesh removal in the operating room (5.8% by 11 years) had lower satisfaction rates (P<0.01) and were defined as having severe mesh exposure. The rates of postoperative pain, reoperation, and Patient Global Impression of Improvement ⩾2 were 2.5%, 3.3%, and 94.2%, respectively. The results of this study implied that TVM treatment gradually increased the symptomatic failure rate but provided durable anatomical support of the vaginal wall. Vaginal mesh exposure was common in women who were largely not sexually active; however, 80% of the cases could be managed in the outpatient clinic, which did not affect patient satisfaction.
引用
收藏
页码:1061 / 1068
页数:7
相关论文
共 185 条
  • [11] Axelsen S(2009)Sexual function and aging in racially and ethnically diverse women J Am Geriatr Soc 57 1362-1368
  • [12] Falconer C(2022)Transvaginal mesh compared with native tissue repair for pelvic organ prolapse Obstet Gynecol 139 975-985
  • [13] Bump RC(2014)Long-term outcomes of synthetic transobturator nonabsorbable anterior mesh versus anterior colporrhaphy in symptomatic, advanced pelvic organ prolapse surgery Int Urogynecol J 25 257-264
  • [14] Mattiasson A(2018)Long term Follow-up of Transvaginal Anatomical Implant of Mesh in Pelvic organ prolapse Sci Rep 8 2829-1139
  • [15] Bø K(2019)Validation of the Chinese version of the Pelvic Floor Distress Inventory-20 (PFDI-20) according to the COSMIN checklist Int Urogynecol J 30 1127-621
  • [16] Brubaker LP(2016)Transvaginal mesh or grafts compared with native tissue repair for vaginal prolapse Cochrane Database Syst Rev 2 CD012079-858
  • [17] DeLancey JOL(2016)Synthetic graft augmentation in vaginal prolapse surgery: long-term objective and subjective outcomes J Minim Invas Gynecol 23 614-640
  • [18] Klarskov P(2018)Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial Int Urogynecol J 29 847-153.e31
  • [19] Shull BL(2017)Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997–2016: a population-based cohort study Lancet 389 629-2002
  • [20] Smith ARB(2021)Effect of sacrospinous hysteropexy with graft vs vaginal hysterectomy with uterosacral ligament suspension on treatment failure in women with uterovaginal prolapse: 5-year results of a randomized clinical trial Am J Obstet Gynecol 225 153.e1-63